From this point of view, NCL exhibits the same characteristics as ER, PR, and HER2 biomarkers, for which negative scoring corresponds to expression similar to the that of normal tissue even though they are essential for clinical stratification of breast cancer. This evidence concerns the gene ERBB2 and breast cancer.